scispace - formally typeset
P

Paul G.H. Mulder

Researcher at Erasmus University Rotterdam

Publications -  366
Citations -  18229

Paul G.H. Mulder is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Fluticasone propionate & Allergy. The author has an hindex of 75, co-authored 365 publications receiving 17308 citations. Previous affiliations of Paul G.H. Mulder include Erasmus University Medical Center.

Papers
More filters
Journal Article

Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging.

R.S. Ramrattan, +5 more
- 01 May 1994 - 
TL;DR: In advanced stages of age-related macular degeneration, the decrease in choriocapillary density and diameter was significantly larger than in normal maculae, but the thickness of the choroid and Bruch's membrane was the same.
Journal ArticleDOI

Incidence of contact-lens-associated microbial keratitis and its related morbidity.

Kam H. Cheng, +6 more
- 17 Jul 1999 - 
TL;DR: The incidence of microbial keratitis among users of extended-wear soft contact lenses in the Netherlands is similar to that reported in the USA during 1989 and awareness of risk factors and improvement in contact-lens materials have not led to a decrease in incidence.
Journal ArticleDOI

Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age

Svati Patandin, +5 more
- 01 Jan 1999 - 
TL;DR: In utero exposure to "background" PCB concentrations is associated with poorer cognitive functioning in preschool children, and children of mothers at the upper end of exposure are especially at risk.
Journal ArticleDOI

Adult Height after Long-Term, Continuous Growth Hormone (GH) Treatment in Short Children Born Small for Gestational Age: Results of a Randomized, Double- Blind, Dose-Response GH Trial

Yvonne van Pareren, +5 more
- 01 Aug 2003 - 
TL;DR: Long-term continuous GH treatment in short children born small for gestational age (SGA) without signs of persistent catch-up growth leads to a normalization of AH, even with a GH dose of 3 IU/m(2).d.
Journal ArticleDOI

Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial

Sevim Uzun, +9 more
- 01 May 2014 - 
TL;DR: Maintenance treatment with azithromycin significantly decreased the exacerbation rate compared with placebo and should therefore be considered for use in patients with COPD who have the frequent exacerbator phenotype and are refractory to standard care.